Quest 10 Wealth Builders Inc. Acquires 4,272 Shares of Axon Enterprise, Inc $AXON

Quest 10 Wealth Builders Inc. boosted its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 25,129.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,289 shares of the biotechnology company’s stock after acquiring an additional 4,272 shares during the period. Axon Enterprise accounts for about 1.3% of Quest 10 Wealth Builders Inc.’s investment portfolio, making the stock its 17th largest position. Quest 10 Wealth Builders Inc.’s holdings in Axon Enterprise were worth $1,812,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Keel Point LLC raised its position in Axon Enterprise by 4.4% during the first quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock worth $254,000 after acquiring an additional 25 shares during the last quarter. Bridgewater Advisors Inc. lifted its holdings in shares of Axon Enterprise by 4.4% in the second quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock valued at $352,000 after purchasing an additional 26 shares in the last quarter. Pinnacle Wealth Planning Services Inc. lifted its holdings in shares of Axon Enterprise by 7.8% in the third quarter. Pinnacle Wealth Planning Services Inc. now owns 361 shares of the biotechnology company’s stock valued at $153,000 after purchasing an additional 26 shares in the last quarter. Roman Butler Fullerton & Co. grew its position in shares of Axon Enterprise by 2.4% in the first quarter. Roman Butler Fullerton & Co. now owns 1,278 shares of the biotechnology company’s stock valued at $500,000 after purchasing an additional 30 shares during the last quarter. Finally, 44 Wealth Management LLC grew its position in shares of Axon Enterprise by 6.0% in the first quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock valued at $225,000 after purchasing an additional 30 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the sale, the chief executive officer owned 3,118,012 shares in the company, valued at approximately $1,587,036,927.88. This trade represents a 0.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the sale, the insider owned 97,761 shares in the company, valued at approximately $61,266,818.70. This trade represents a 8.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 37,397 shares of company stock worth $21,234,034. Corporate insiders own 4.20% of the company’s stock.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported record Q3 revenue of $909 million, up 28% year over year, and returned to net income. Adjusted EBITDA rose 33% to $236 million. Axon Q3 results
• Positive Sentiment: Growth in newer offerings was strong: Drone as First Responder software and services revenue grew 43%, Platform Solutions revenue climbed 106%, and AI annual recurring revenue exceeded $100 million. Axon Q3 results
• Positive Sentiment: Axon invested an additional $1.2 billion in Skydio, raising its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The deal could strengthen Axon’s drone-response offering, though it requires substantial capital. Axon Skydio investment
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of about $909 million both missed analyst estimates, despite solid year-over-year growth. Q3 earnings and revenue miss
• Negative Sentiment: Axon’s Q4 revenue outlook of $990 million–$1.0 billion was below the roughly $1.1 billion consensus, while its full-year 2026 revenue outlook of $3.6 billion also trailed expectations of about $3.7 billion. Revenue outlook and Skydio investment
• Negative Sentiment: Zacks Research downgraded Axon from “strong buy” to “hold.” A lawsuit over the company’s AI-powered license-plate-reader network also presents potential legal uncertainty. License plate reader lawsuit

Axon Enterprise Trading Down 9.8%

Shares of AXON stock opened at $382.56 on Friday. The company has a market capitalization of $31.08 billion, a price-to-earnings ratio of 158.74, a PEG ratio of 8.06 and a beta of 1.48. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The firm has a 50-day moving average price of $447.49 and a 200 day moving average price of $476.73. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $665.07.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.89 by ($0.17). The firm had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. Axon Enterprise’s revenue for the quarter was up 27.8% on a year-over-year basis. During the same period in the prior year, the business earned $1.17 earnings per share. Research analysts forecast that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently weighed in on AXON. Northcoast Research raised their price objective on shares of Axon Enterprise from $650.00 to $680.00 and gave the stock a “buy” rating in a research note on Tuesday, August 11th. Piper Sandler cut their price objective on Axon Enterprise from $732.00 to $561.00 and set an “overweight” rating for the company in a research report on Tuesday, October 20th. UBS Group upped their target price on Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a research note on Thursday, August 6th. Raymond James Financial set a $675.00 target price on Axon Enterprise in a report on Thursday, October 15th. Finally, Needham & Company LLC reiterated a “buy” rating on shares of Axon Enterprise in a report on Tuesday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and an average price target of $688.38.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.